|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Alzheimer's Disease
|
NIA
|
2R01AG014713-11
|
|
PS1 and BACE1 regulate processing and activity of voltage-gated sodium channels
|
KOVACS, DORA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$323,644
|
|
Alzheimer's Disease
|
NIMH
|
4R37MH060009-09
|
|
Identification and Characterization of Novel AD Genes
|
TANZI, RUDOLPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$785,119
|
|
Alzheimer's Disease
|
NIGMS
|
5R01GM031847-25
|
|
Hydrogen exchange, proteins, folding, and misfolding
|
ENGLANDER, S.
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$369,812
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH047346-14
|
|
Morphologic/Neurochemical Correlates of Depression in AD
|
ZUBENKO, GEORGE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$634,059
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH060883-08
|
|
Corticolimbic Degeneration and Treatment of Dementia
|
CSERNANSKY, JOHN
|
WASHINGTON UNIVERSITY
|
MO
|
$359,621
|
|
Alzheimer's Disease
|
NINDS
|
5K99NS057906-02
|
|
Imaging nerve growth factor signal transduction in live neurons
|
CUI, BIANXIAO
|
STANFORD UNIVERSITY
|
CA
|
$59,238
|
|
Alzheimer's Disease
|
NIA
|
1R43AG029006-01A1
|
|
DETECTION OF ALZHEIMER'S DISEASE USING A POLYMER NANOWIRE-BASED BIOSENSOR
|
ALAM, MAKSUDUL
|
INNOSENSE, LLC
|
CA
|
$167,753
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH069585-05
|
|
APP, Alzheimer's Disease, and Synaptic Function
|
SUDHOF, THOMAS
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$525,144
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH060013-09
|
|
Neuromodulation and Cortical Memory Function
|
HASSELMO, MICHAEL
|
BOSTON UNIVERSITY
|
MA
|
$344,546
|
|
Alzheimer's Disease
|
NIMH
|
5K01MH068351-07
|
|
Psychiatric Characterization/Mild Cognitive Impairment
|
GEDA, YONAS
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$158,338
|
|
Alzheimer's Disease
|
FIC
|
5R03TW007171-02
|
|
Senile Degeneration in the Brain of Octogon Degus
|
KIRKWOOD, ALFREDO
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$38,624
|
|
Alzheimer's Disease
|
NIA
|
5F32AG027647-03
|
|
Structure of signal peptide peptidase
|
LIEBERMAN, RAQUEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$3,483
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH054846-12
|
|
Geriatric Depression: Risk Factors for Adverse Outcomes
|
STEFFENS, DAVID
|
DUKE UNIVERSITY
|
NC
|
$560,873
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH074692-02
|
|
Medial temporal lobe contributions to episodic memory
|
DAVACHI, LILA
|
NEW YORK UNIVERSITY
|
NY
|
$302,250
|
|
Alzheimer's Disease
|
NIMH
|
5F31MH073369-03
|
|
The role of acetylcholine in the perirhinal cortex
|
BARTKO, SUSAN
|
UNIVERSITY OF CAMBRIDGE
|
UK
|
$42,222
|
|
Alzheimer's Disease
|
NINR
|
5R01NR004345-10
|
|
Relaxation Therapy for Alzheimer's Caregivers
|
LEWIS, SHARON
|
UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT
|
TX
|
$429,716
|
|
Alzheimer's Disease
|
NINDS
|
5R21NS052385-02
|
|
Effects of oxidative stress on glial cell membranes
|
LEE, JAMES
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$160,855
|
|
Alzheimer's Disease
|
NINDS
|
1R21NS056325-01A1
|
|
Small Molecules as Modulators of Polyglutamine Aggregation
|
BERTHELIER, VALERIE
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$197,761
|
|
Alzheimer's Disease
|
NIA
|
1K23AG028982-01A1
|
|
FMRI: Prediction of Mild Cognitive Impairment In Geriatric Depression
|
WANG, LIHONG
|
DUKE UNIVERSITY
|
NC
|
$6,078
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027973-02
|
|
Role of ABCA1 in neurodegeneration
|
KOLDAMOVA, RADOSVETA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$253,942
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH028783-32
|
|
Psychopharmacological Effects of Exogenous Choline
|
WURTMAN, RICHARD
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$333,760
|
|
Alzheimer's Disease
|
NINDS
|
5K23NS048302-04
|
|
A Novel MRI Biomarker for Incipient Alzheimer's Disease
|
GREICIUS, MICHAEL
|
STANFORD UNIVERSITY
|
CA
|
$173,701
|
|
Alzheimer's Disease
|
NIA
|
5R01AG029385-02
|
|
Conformational Dynamics in Pin1 REgulation of APP Processing and Abeta Production
|
NICHOLSON, LINDA
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$434,468
|
|
Alzheimer's Disease
|
NIA
|
5R01AG018917-06
|
|
A Multidisciplinary Analysis of Gelsolin Amyloid Disease
|
KELLY, JEFFERY
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$501,754
|
|
Alzheimer's Disease
|
NIA
|
5R01AG026478-02
|
|
Mechanism of Abeta Sequestration
|
TURNER, RAYMOND
|
GEORGETOWN UNIVERSITY
|
DC
|
$280,617
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH079084-02
|
|
Cognitive Modulation of Circadian Rhythms
|
LEE, THERESA
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$295,054
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH055687-13
|
|
Associative Processes in Episodic Memory
|
KAHANA, MICHAEL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$267,814
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS046517-04
|
|
Estrogen, androgen, neprilysin, and amyloid peptides.
|
HERSH, LOUIS
|
UNIVERSITY OF KENTUCKY
|
KY
|
$224,858
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS047237-05
|
|
Modifiers of Huntingtin and Alpha-synuclein Toxicity
|
MUCHOWSKI, PAUL
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$378,893
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS041787-07
|
|
Roles of Amyloid Precursor Protein and its Metabolites in Neuronal Impairment
|
MUCKE, LENNART
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$510,839
|
|
Alzheimer's Disease
|
NIA
|
1R01AG031221-01
|
|
Targeting the apoE/ABeta Interaction as a Novel AD Therapy
|
SADOWSKI, MARTIN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$312,267
|
|
Alzheimer's Disease
|
NIA
|
5R01AG020159-07
|
|
Mucosal Abeta Vaccination: Modulating the Immune Response
|
LEMERE, CYNTHIA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$324,134
|
|
Alzheimer's Disease
|
NIA
|
5R21AG027794-02
|
|
Curcumin-based analogs as improved inhibitors of Abeta aggregation
|
ORLANDO, ROBERT
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$145,185
|
|
Alzheimer's Disease
|
NIA
|
5R01AG025952-02
|
|
Role of BACE stabilization in Alzheimer's Disease (AD)
|
TESCO, GIUSEPPINA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$316,418
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027910-02
|
|
Age-Related Decrease in A-Beta Peptide Clearance Pathways: CSF and BBB
|
JOHANSON, CONRAD
|
RHODE ISLAND HOSPITAL (PROVIDENCE, RI)
|
RI
|
$313,879
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027854-02
|
|
Modulation of ABeta Deposition by Environmental Enrichment
|
SISODIA, SANGRAM
|
UNIVERSITY OF CHICAGO
|
IL
|
$386,572
|
|
Alzheimer's Disease
|
NINDS
|
5F30NS048776-04
|
|
Ultrasensitive Detection in Clear and Turbid Media
|
TAHARI, ABDEL
|
UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN
|
IL
|
$16,875
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS055118-02
|
|
Cerebral Microvascular Amyloid: Neuroinflammation and Cognitive Deficits
|
VAN NOSTRAND, WILLIAM
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$337,399
|
|
Alzheimer's Disease
|
NIA
|
5R21AG026646-02
|
|
Mitochondrial dysfunction and Alzheimer's disease
|
MURDOCK, DEBORAH
|
VANDERBILT UNIVERSITY
|
TN
|
$159,832
|
|
Alzheimer's Disease
|
NIGMS
|
5R01GM075331-02
|
|
Structure Prediction of Helical Transmembrane Proteins
|
XU, YING
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$313,889
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS038104-09
|
|
Pathophysiology of Traumatic Axonal Injury
|
SMITH, DOUGLAS
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$347,538
|
|
Alzheimer's Disease
|
NINDS
|
5K23NS050305-05
|
|
MRI Studies of MTL Structure and Function in MCI and AD
|
BREWER, JAMES
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$175,557
|
|
Alzheimer's Disease
|
NIA
|
3P01AG026276-03S2
|
|
Antedecent Biomarkers for AD: The Adult Children Study Biomarkers Core
|
MORRIS, JOHN
|
WASHINGTON UNIVERSITY
|
MO
|
$79,728
|
|
Alzheimer's Disease
|
NIA
|
2P01AG005119-20A1
|
9003
|
ADMINISTRATIVE CORE
|
MARKESBERY, WILLIAM
|
UNIVERSITY OF KENTUCKY
|
KY
|
$94,135
|
|
Alzheimer's Disease
|
NIA
|
2P01AG005119-20A1
|
9004
|
BETA-AMYLOID CORE
|
MURPHY, PAUL
|
UNIVERSITY OF KENTUCKY
|
KY
|
$290,512
|
|
Alzheimer's Disease
|
NIA
|
2P01AG005119-20A1
|
9005
|
ANIMAL CORE
|
ST CLAIR, DARET
|
UNIVERSITY OF KENTUCKY
|
KY
|
$226,388
|
|
Alzheimer's Disease
|
NIA
|
2P01AG005119-20A1
|
0009
|
BETA AMYLOID-INDUCED RNA OXIDATION AS A MEDIATOR OF AD PATHOGENESIS
|
MARKESBERY, WILLIAM
|
UNIVERSITY OF KENTUCKY
|
KY
|
$244,923
|
|
Alzheimer's Disease
|
NIA
|
2P01AG005119-20A1
|
0010
|
BRAIN PROTEIN OXIDATION IN AD, MCI, AND PCAD: ROLES OF AB AND PIN1
|
BUTTERFIELD, D.
|
UNIVERSITY OF KENTUCKY
|
KY
|
$380,033
|
|
Alzheimer's Disease
|
NIA
|
2P01AG005119-20A1
|
0011
|
AB AND RAGE INTERACTIONS IN ALZHEIMER'S DIESEASE
|
KELLER, JEFFREY
|
UNIVERSITY OF KENTUCKY
|
KY
|
$292,215
|
|
Alzheimer's Disease
|
NIA
|
2P01AG005119-20A1
|
0012
|
AB AND NADPH OXIDASE IN MILD COGNITIVE IMPAIRMENT AND ALZHEIMER'S DISEASE
|
BRUCE-KELLER, ANNADORA
|
UNIVERSITY OF KENTUCKY
|
KY
|
$265,755
|
|
Alzheimer's Disease
|
NIA
|
5R44AG026841-03
|
|
Translating Dementia Care Research: Sleep Behavior Disorders
|
HARRIS, CATHERINE
|
LIGHTBRIDGE HEALTHCARE RESEARCH, INC.
|
TX
|
$444,434
|
|
Alzheimer's Disease
|
NIA
|
2P01AG000538-29A1
|
9002
|
ADMINISTRATIVE CORE
|
COTMAN, CARL
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$89,083
|
|
Alzheimer's Disease
|
NIA
|
2P01AG000538-29A1
|
9003
|
TISSUE AND PEPTIDE RESOURCES CORE
|
HEAD, ELIZABETH
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$527,556
|
|
Alzheimer's Disease
|
NIA
|
2P01AG000538-29A1
|
0022
|
DIVERSITY OF AMYLOID OLIGOMER ASSEMBLY STATES AND ROLES IN AD PATHOGENESIS
|
GLABE, CHARLES
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$243,643
|
|
Alzheimer's Disease
|
NIA
|
2P01AG000538-29A1
|
0023
|
AB AND IL - 1B SUPPRESS BDNF SIGNALING AND THE REGULATION OF SYNAPTIC PLASTICITY
|
COTMAN, CARL
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$250,102
|
|
Alzheimer's Disease
|
NIA
|
2P01AG000538-29A1
|
0024
|
ROLE OF INFLAMMATION ON INDUCTION OF TAU PATHOLOGY IN THE BRAINS OF TRANSGENIC MI
|
LAFERLA, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$245,399
|
|
Alzheimer's Disease
|
NIA
|
2P01AG000538-29A1
|
0025
|
INVESTIGATION OF COMPLEMENT INDUCED NEUROTOXIC AND NEUROPROTECTIVE PATHWAYS
|
TENNER, ANDREA
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$242,253
|
|
Alzheimer's Disease
|
NIA
|
2P01AG000538-29A1
|
0026
|
OLIGOMERIC AB AND INFLAMMATION IN NEUROVASCULAR PATHOGENESIS IN AD
|
CRIBBS, DAVID
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$245,936
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027936-02
|
|
Structural Analysis of IAPP Fibril Formation and Membrane Interaction
|
LANGEN, RALF
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$294,720
|
|
Alzheimer's Disease
|
NINDS
|
5F31NS054513-03
|
|
Yeast Model of Disease Associated Mutant Ubiquitin
|
TANK, ELIZABETH
|
WASHINGTON UNIVERSITY
|
MO
|
$27,067
|
|
Alzheimer's Disease
|
NIA
|
2P01AG014449-11A1
|
9002
|
ADMINISTRATIVE CORE
|
MUFSON, ELLIOTT
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$224,580
|
|
Alzheimer's Disease
|
NIA
|
2P01AG014449-11A1
|
9003
|
STATISTICAL AND DATA MANAGEMENT CORE
|
LEURGANS, SUE
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$247,311
|
|
Alzheimer's Disease
|
NIA
|
2P01AG014449-11A1
|
0005
|
NEUROFIBRILLARY TANGLES EVOLUTION IN MILD COGNITIVE IMPAIRMENT
|
BINDER, LESTER
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$289,817
|
|
Alzheimer's Disease
|
NIA
|
2P01AG014449-11A1
|
0006
|
LR11, A NOVEL RECEPTOR IN MILD COGNITIVE IMPAIRMENT
|
LEVEY, ALLAN
|
EMORY UNIVERSITY
|
GA
|
$273,364
|
|
Alzheimer's Disease
|
NIA
|
2P01AG014449-11A1
|
0007
|
CHOLINOTROPHIC ALTERATIONS IN MILD COGNITIVE IMPAIRMENT
|
MUFSON, ELLIOTT
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$484,409
|
|
Alzheimer's Disease
|
NIA
|
2P01AG014449-11A1
|
0008
|
SYNAPTIC, CHOLINERGIC AND AMYLOID ALTERATIONS IN MILD COGNITIVE IMPAIRMENT
|
DEKOSKY, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$315,366
|
|
Alzheimer's Disease
|
NINDS
|
5K08NS053899-03
|
|
Cerebral Amyloid Angiopathy, Vascular Dysfunction & Ischemic Brain Injury
|
ZIPFEL, GREGORY
|
WASHINGTON UNIVERSITY
|
MO
|
$157,583
|
|
Alzheimer's Disease
|
NIA
|
1U01AG031106-01
|
|
Novel Hsp90 Inhibitors to Reduce Misfolded Proteins in Alzheimer's Disease
|
MICHAELIS, MARY
|
UNIVERSITY OF KANSAS LAWRENCE
|
KS
|
$523,118
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH069456-05
|
|
Modeling the Neural Basis of Episodic Memory
|
NORMAN, KENNETH
|
PRINCETON UNIVERSITY
|
NJ
|
$240,425
|
|
Alzheimer's Disease
|
NIA
|
1U01AG031115-01
|
|
Development of Allopregnanolone as a Neurogenic Regenerative Therapeutic
|
BRINTON, ROBERTA
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$644,539
|
|
Alzheimer's Disease
|
NICHD
|
5R01HD014959-22
|
|
Maturation of Cognitive-Related Brain Potentials
|
FRIEDMAN, DAVID
|
NEW YORK STATE PSYCHIATRIC INSTITUTE
|
NY
|
$309,172
|
|
Alzheimer's Disease
|
NIA
|
5R01AG028158-02
|
|
Mechanism and structural basis of amyloid fibril formation by serum amyloid A
|
COLON, WILFREDO
|
RENSSELAER POLYTECHNIC INSTITUTE
|
NY
|
$210,547
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027859-02
|
|
Amyloid Imaging in Frontotemporal Dementia and Alzheimer's Disease
|
JAGUST, WILLIAM
|
UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB
|
CA
|
$397,588
|
|
Alzheimer's Disease
|
NIA
|
5R01AG020729-06
|
|
Mitochondrial Dysfunction in Alzheimer's Disease
|
LIN, MICHAEL
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$337,512
|
|
Alzheimer's Disease
|
NINR
|
1R03NR010582-01
|
|
Examining Perceived Stigma in Persons with Dementia
|
BURGENER, SANDRA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$89,479
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027855-02
|
|
Vascular Mechanisms of Neuronal Circuit Disruption in Dementia
|
GRUTZENDLER, JAIME
|
NORTHWESTERN UNIVERSITY
|
IL
|
$248,606
|
|
Alzheimer's Disease
|
NIA
|
1R21AG031388-01
|
|
Pathogenic Template of Natural Oligomer of Beta-Amyloid in Alzheimer's Disease
|
GONG, YUESONG
|
DREXEL UNIVERSITY
|
PA
|
$159,375
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS041783-07
|
|
Presenilins in Synaptic Plasticity and Neurodegeneration
|
SHEN, JIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$355,087
|
|
Alzheimer's Disease
|
NIA
|
1R21AG031380-01
|
|
Proteomic analysis of Amyloid Precursor Protein signaling: mediators of toxicity
|
KOURAKINE, ALEXEI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$186,680
|
|
Alzheimer's Disease
|
NCCAM
|
5R21AT002959-02
|
|
MBSR Intervention to reduce stress in AD caregivers
|
FREDMAN, LISA
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$278,688
|
|
Alzheimer's Disease
|
NIA
|
1R33AG031485-01
|
|
P-glycoprotein and Alzheimer's Disease
|
UNADKAT, JASHVANT
|
UNIVERSITY OF WASHINGTON
|
WA
|
$317,157
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS041355-07
|
|
Molecular Probes for Alzheimer's Gamma-Secretase
|
WOLFE, MICHAEL
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$382,813
|
|
Alzheimer's Disease
|
NIA
|
1R21AG031437-01
|
|
Targeting A-beta with evolved site-specific proteases
|
SAVINOV, SERGEY
|
PURDUE UNIVERSITY WEST LAFAYETTE
|
IN
|
$162,031
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS037853-11
|
|
OVEREXPRESSION OF APP AND CEREBROVASCULAR REGULATION
|
IADECOLA, COSTANTINO
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$367,500
|
|
Alzheimer's Disease
|
NICHD
|
1R01HD057564-01
|
|
Perinatal choline therapy in a mouse model of Down Syndrome & Alzheimer's Disease
|
STRUPP, BARBARA
|
CORNELL UNIVERSITY ITHACA
|
NY
|
$623,872
|
|
Alzheimer's Disease
|
NEI
|
5R21EY017852-02
|
|
Treatment of BIGH3-related Corneal Dystrophies with Meptides
|
YUAN, CHING
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$183,138
|
|
Alzheimer's Disease
|
NIA
|
5R01AG018402-06
|
|
Amyloid Imaging Agents for Position Emission Tomography
|
MATHIS, CHESTER
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$376,408
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH080405-02
|
|
Plasma and CSF Abeta peptides in late-onset major depression
|
POMARA, NUNZIO
|
NATHAN S. KLINE INSTITUTE FOR PSYCH RES
|
NY
|
$391,648
|
|
Alzheimer's Disease
|
NIA
|
2R01AG017917-06A2
|
|
Epidemiologic Study of Neural Reserve and Neurobiology of Aging
|
BENNETT, DAVID
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$1,607,814
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS048263-05
|
|
Altered Glial Calcium Signaling in Neurodegeneration
|
GOLOVINA, VERA
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$260,490
|
|
Alzheimer's Disease
|
NIA
|
2R01AG018023-06A2
|
|
Plasma AB as a Surrogate Genetic Marker for LOAD
|
YOUNKIN, STEVEN
|
MAYO CLINIC COLL OF MED, JACKSONVILLE
|
FL
|
$319,814
|
|
Alzheimer's Disease
|
NIA
|
3R01AG022018-04S1
|
|
Risk Factors for Cognitive Decline in African Americans
|
BARNES-YOUNG, LISA
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$189,296
|
|
Alzheimer's Disease
|
NIA
|
5R01AG018416-07
|
|
Structure/function analysis of A-beta fibril assembly
|
WETZEL, RONALD
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$343,534
|
|
Alzheimer's Disease
|
NIA
|
5R01AG028108-02
|
|
Mechanisms of Tauopathies and Synucleopathies
|
SIDHU, ANITA
|
GEORGETOWN UNIVERSITY
|
DC
|
$318,580
|
|
Alzheimer's Disease
|
NIA
|
7R01AG027081-04
|
|
Nox Isoforms and Vascular Cell Phenotype
|
KEANEY, JOHN
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$301,995
|
|
Alzheimer's Disease
|
NIA
|
5R21AG031037-02
|
|
Nicotine/Cannabinoid Therapy for Alzheimer's Disease
|
SHYTLE, R.
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$181,178
|
|
Alzheimer's Disease
|
NIA
|
5R01AG023104-05
|
|
Biochemistry of Nicastrin in the Gamma-Secretase Complex
|
YU, GANG
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$289,915
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027435-03
|
|
Evolution of memory-related fMRI activation over the course of MCI and AD
|
SPERLING, REISA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$1,171,848
|
|
Alzheimer's Disease
|
NIA
|
5K01AG024079-03
|
|
Neurofibrillary Tangle-Induced Dementia in AD
|
DUNCKLEY, TRAVIS
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
AZ
|
$115,630
|
|
Alzheimer's Disease
|
NIA
|
5R01AG024688-03
|
|
Anti-oxidant therapy in Alzheimer's disease
|
BACSKAI, BRIAN
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$261,400
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH043832-20
|
|
Maintenance Therapies in Late-Life Depression-III
|
POLLOCK, BRUCE
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$615,139
|
|
Alzheimer's Disease
|
NIA
|
5R01AG018478-08
|
|
Functional Consequences of Vaccination in AD Tg Mice
|
MORGAN, DAVID
|
UNIVERSITY OF SOUTH FLORIDA
|
FL
|
$275,322
|
|
Alzheimer's Disease
|
NIA
|
5R01AG023524-04
|
|
Amyloid Beta-Protein: ApoE and Cholesterol Homeostasis
|
WOOD, WELLINGTON
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$237,184
|
|
Alzheimer's Disease
|
NIA
|
5R01AG023138-05
|
|
Antioxidant vitamins in models of Alzheimer's Disease
|
MAY, JAMES
|
VANDERBILT UNIVERSITY
|
TN
|
$299,918
|
|
Alzheimer's Disease
|
NIA
|
5R01AG021612-05
|
|
Muscarinic Receptor Induced LTD in Rat Hippocampus
|
MCMAHON, LORI
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$297,095
|
|
Alzheimer's Disease
|
NIA
|
5R01AG025493-04
|
|
Roles of Reticulon proteins in neurodegenerative disease
|
YAN, RIQIANG
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$291,450
|
|
Alzheimer's Disease
|
NIA
|
5R37AG012406-14
|
|
LRP AND ALZHEIMER'S DISEASE
|
HYMAN, BRADLEY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$436,075
|
|
Alzheimer's Disease
|
NIA
|
5R01AG025161-04
|
|
MRI and mouse models of Alzheimer's disease and aging
|
SMALL, SCOTT
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$306,922
|
|
Alzheimer's Disease
|
NIA
|
5K07AG021582-03
|
|
NIA Academic Career Leadership Award in Alzheimer's Disease
|
ASTHANA, SANJAY
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$108,000
|
|
Alzheimer's Disease
|
NHLBI
|
5R01HL063762-09
|
|
Metabolism of the VLDL receptor and ApoE receptor 2
|
HERZ, JOACHIM
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$332,812
|
|
Alzheimer's Disease
|
NIA
|
1R01AG028679-01A2
|
|
Role of Cell Cycle in Neurodegeneration
|
SMITH, MARK
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$320,141
|
|
Alzheimer's Disease
|
NHLBI
|
5R01HL056083-13
|
|
Structural Basis of the Interactions of Apolipoprotein E
|
LUND-KATZ, SISSEL
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$399,728
|
|
Alzheimer's Disease
|
NIA
|
5K23AG023675-04
|
|
Oxidative Stress, Aging and Alzheimer's Disease
|
ARVANITAKIS, ZOE
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$154,913
|
|
Alzheimer's Disease
|
NIA
|
7R01AG021134-05
|
|
Light Treatment for Sleep/Wake Disturbances AD
|
YESAVAGE, JEROME
|
PALO ALTO INSTITUTE FOR RES & EDU, INC.
|
CA
|
$318,723
|
|
Alzheimer's Disease
|
NIA
|
5R01AG014473-12
|
|
Apolipoprotein E receptors and Alzheimers disease
|
REBECK, G.
|
GEORGETOWN UNIVERSITY
|
DC
|
$275,802
|
|
Alzheimer's Disease
|
NINDS
|
1R01NS055804-01A2
|
|
Mechanisms of synapse dysfunction in Alzheimer's disease
|
SULLIVAN, JANE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$306,681
|
|
Alzheimer's Disease
|
NIA
|
1R01AG029977-01A1
|
|
Neuroimaging Biomarkers in Mouse Models of AD
|
PAUTLER, ROBIA
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$314,675
|
|
Alzheimer's Disease
|
NIA
|
2R01AG022559-04A1
|
|
PET Imaging of Abeta Plaques in Alzheimer?s Disease
|
KUNG, HANK
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$322,875
|
|
Alzheimer's Disease
|
NINDS
|
1R01NS059005-01A1
|
|
CD36 in Alzheimer's Disease
|
EL-KHOURY, JOSEPH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$363,125
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS049442-04
|
|
Mechanisms of Synaptic Dysfunction by Amyloid Peptides
|
ARANCIO, OTTAVIO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$405,421
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS035010-12
|
|
Structure and Function of Tau Protein
|
FEINSTEIN, STUART
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
CA
|
$316,470
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH038623-27
|
|
Aging and Dementia: Cholinergic neuron biochemistry
|
DAVIES, PETER
|
YESHIVA UNIVERSITY
|
NY
|
$338,491
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH061465-08
|
|
Cholinergic and GABAergic Mechanisms in the Septohippocampal Pathway
|
ALREJA, MEENAKSHI
|
YALE UNIVERSITY
|
CT
|
$300,222
|
|
Alzheimer's Disease
|
NIA
|
2R01AG012749-13
|
|
Protein-Protein Interactions in the Biology of Beta-APP
|
SELKOE, DENNIS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$341,759
|
|
Alzheimer's Disease
|
NIA
|
1R01AG028688-01A2
|
|
Evaluation of a Novel Amyloid Plaque SPECT Tracer for Diagnosing AD
|
NEWBERG, ANDREW
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$321,694
|
|
Alzheimer's Disease
|
NIA
|
1R01AG031553-01A2
|
|
Epidemiologic Study of Brain Vitamin E, Diet & Age-Related Neurologic Diseases
|
MORRIS, MARTHA
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$687,427
|
|
Alzheimer's Disease
|
NIA
|
2R01AG020098-06A2
|
|
Predictors of Alheimers Disease in Mild Cognitive Impairment
|
LOPEZ, OSCAR
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$414,082
|
|
Alzheimer's Disease
|
NIA
|
5R01AG023597-05
|
|
Reactive gamma-Ketoaldehydes in Dementia
|
ROBERTS, L
|
VANDERBILT UNIVERSITY
|
TN
|
$263,503
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027443-03
|
|
Pathogenic Mechanisms of Cell-Derived Abeta Oligomers
|
SELKOE, DENNIS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$504,108
|
|
Alzheimer's Disease
|
NIA
|
5R01AG025500-03
|
|
Inhibition of Alzheimer's Beta-Amyloid Fibril Formation
|
HUA, DUY
|
KANSAS STATE UNIVERSITY
|
KS
|
$261,009
|
|
Alzheimer's Disease
|
NIA
|
5R01AG016839-09
|
|
Functional Studies of Calmyrin
|
MONTEIRO, MERVYN
|
UNIVERSITY OF MD BIOTECHNOLOGY INSTITUTE
|
MD
|
$282,877
|
|
Alzheimer's Disease
|
NIA
|
5R01AG022512-06
|
|
Oxidative stress, Homocysteine and Alzheimer's Disease
|
PRATICO, DOMENICO
|
TEMPLE UNIVERSITY
|
PA
|
$223,013
|
|
Alzheimer's Disease
|
NIA
|
5R01AG023593-05
|
|
Novel Mouse Model to Dissect Alzheimer's Disease Pathophysiology
|
BOWERS, WILLIAM
|
UNIVERSITY OF ROCHESTER
|
NY
|
$249,556
|
|
Alzheimer's Disease
|
NINDS
|
5K23NS048855-04
|
|
Ocular motor function and decision-making in FTLD
|
BOXER, ADAM
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$160,963
|
|
Alzheimer's Disease
|
NIMH
|
2R01MH061492-06A2
|
|
Mechanisms of Entorhinal Cortex Function
|
HASSELMO, MICHAEL
|
BOSTON UNIVERSITY
|
MA
|
$318,096
|
|
Alzheimer's Disease
|
NIA
|
5F31AG023486-05
|
|
Minority Predoctoral Fellowship Program
|
GOODWIN, COURTNEY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$44,097
|
|
Alzheimer's Disease
|
NIA
|
5R37AG011385-15
|
|
Transgenic Models to Study Alzheimer's Disease
|
MUCKE, LENNART
|
J. DAVID GLADSTONE INSTITUTES
|
CA
|
$470,681
|
|
Alzheimer's Disease
|
NIA
|
1R01AG029839-01A1
|
|
Oxidative Dysfunction of LRP at the Blood-brain Barrier in Alzheimer's Disease
|
BANKS, WILLIAM
|
SAINT LOUIS UNIVERSITY
|
MO
|
$310,584
|
|
Alzheimer's Disease
|
NIA
|
2R01AG019241-06A2
|
|
Prevention of Alzheimer's Diseae by Vitamin E and Selenium
|
MARKESBERY, WILLIAM
|
UNIVERSITY OF KENTUCKY
|
KY
|
$1,304,793
|
|
Alzheimer's Disease
|
NINDS
|
1R01NS055223-01A2
|
|
Presenilins and Cell Adhesion Molecules
|
PARENT, ANGELE
|
UNIVERSITY OF CHICAGO
|
IL
|
$335,781
|
|
Alzheimer's Disease
|
NIEHS
|
1R01ES014826-01A2
|
|
Cholesterol induces oxidative stress and triggers iron and A? accumulation
|
GHRIBI, OTHMAN
|
UNIVERSITY OF NORTH DAKOTA
|
ND
|
$288,563
|
|
Alzheimer's Disease
|
NIA
|
1R01AG029481-01A1
|
|
Copper's Role in Brain LRP-mediated Abeta Efflux and Aging
|
DEANE, RASHID
|
UNIVERSITY OF ROCHESTER
|
NY
|
$252,560
|
|
Alzheimer's Disease
|
NIA
|
1R01AG027771-01A2
|
|
Neuroimaging Study on Function-Structure Relationship of Olfactory Deficit in AD
|
YANG, QING
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
PA
|
$294,602
|
|
Alzheimer's Disease
|
NIA
|
1R01AG030027-01A1
|
|
Aging and the Tissue Response to Misfolded Proteins
|
BUXBAUM, JOEL
|
SCRIPPS RESEARCH INSTITUTE
|
CA
|
$388,475
|
|
Alzheimer's Disease
|
NIA
|
9R01AG032132-14
|
|
Control of AMPA Receptor Trafficking by Beta Amyloid
|
MALINOW, ROBERTO
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$500,013
|
|
Alzheimer's Disease
|
NIA
|
1R01AG027465-01A2
|
|
ApoE and Cholesterol Effects on Amyloid-beta in Synaptic Terminals in AD
|
GYLYS, KAREN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$268,907
|
|
Alzheimer's Disease
|
NHLBI
|
5F31HL085930-02
|
|
Hyposialylation Regulates Alpha4Beta1 Integrin Binding to VCAM1
|
WOODARD-GRICE, ALENCIA
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$30,292
|
|
Alzheimer's Disease
|
NIMH
|
5K02MH001621-11
|
|
Monoamiergic Function in Geriatric Psychiatry
|
SMITH, GWENN
|
FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH
|
NY
|
$124,416
|
|
Alzheimer's Disease
|
NIA
|
2R01AG020197-06A2
|
|
Immune Therapy and Imaging in Mouse and Primate Models of Alzheimer's Disease
|
SIGURDSSON, EINAR
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$352,601
|
|
Alzheimer's Disease
|
NIA
|
5R01AG023739-04
|
|
Androgens and Alzheimer's Disease
|
PIKE, CHRISTIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$248,399
|
|
Alzheimer's Disease
|
NIA
|
5R01AG022099-04
|
|
Gene detection in regions linked to Alzheimer's disease
|
AVRAMOPOULOS, DIMITRIOS
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$383,009
|
|
Alzheimer's Disease
|
NIDDK
|
5K08DK071136-03
|
|
The Role of Oxidative Stress in Systemic Amyloidosis
|
ZELDENRUST, STEVEN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$127,144
|
|
Alzheimer's Disease
|
NIGMS
|
2R01GM067785-05A1
|
|
Hsp40 and conformational disease
|
CYR, DOUGLAS
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$288,785
|
|
Alzheimer's Disease
|
NIA
|
1R01AG027944-01A2
|
|
Genomic Convergence in Alzheimer Disease
|
PERICAK-VANCE, MARGARET
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
FL
|
$1,210,759
|
|
Alzheimer's Disease
|
NIA
|
7R01AG027233-03
|
|
Nectin-1: Synaptic processing and functions
|
FEDEROFF, HOWARD
|
GEORGETOWN UNIVERSITY
|
DC
|
$299,439
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027040-03
|
|
Genomic Analysis of Human Aging and Cognitive Decline
|
YANKNER, BRUCE
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
MA
|
$313,453
|
|
Alzheimer's Disease
|
NIA
|
5R21AG029268-02
|
|
Mechanisms and use of antidiabetic agents in brain aging and Alzheimer's disease
|
THIBAULT, OLIVIER
|
UNIVERSITY OF KENTUCKY
|
KY
|
$152,543
|
|
Alzheimer's Disease
|
NIA
|
1R03AG030060-01A1
|
|
Fyn modulation of APP processing
|
REBECK, G.
|
GEORGETOWN UNIVERSITY
|
DC
|
$65,238
|
|
Alzheimer's Disease
|
NIA
|
1R01AG030048-01A1
|
|
A Phase 2 Trial of AAV-NGF Gene Delivery in Alzheimer's Disease
|
AISEN, PAUL
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$2,095,517
|
|
Alzheimer's Disease
|
NIA
|
5R37AG015473-10
|
|
Genetic Epidemiology of Alzheimer's Disease in Hispanics
|
MAYEUX, RICHARD
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$1,090,495
|
|
Alzheimer's Disease
|
NIA
|
5R01AG019085-07
|
|
Genetic Studies of Dementia in the Amish
|
HAINES, JONATHAN
|
VANDERBILT UNIVERSITY
|
TN
|
$1,098,154
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH070886-04
|
|
MCI, APOE and Sleep Apnea: Effects on Cognition
|
O'HARA, RUTH
|
STANFORD UNIVERSITY
|
CA
|
$306,665
|
|
Alzheimer's Disease
|
NIA
|
9R01AG031581-10
|
|
PET, APOE & the Preclinical Course of Alzheimer's Disease
|
REIMAN, ERIC
|
BANNER ALZHEIMER'S INSTITUTE
|
AZ
|
$1,303,134
|
|
Alzheimer's Disease
|
NIA
|
2R01AG017138-06A2
|
|
Pathogenic mechanisms of presenilin mutation
|
SIMAN, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$326,957
|
|
Alzheimer's Disease
|
NIA
|
5R01AG021927-05
|
|
Functional Change in Mild Cognitive Impairment
|
MARSON, DANIEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$307,783
|
|
Alzheimer's Disease
|
NIA
|
5F31AG026852-02
|
|
Cell Loss in an Alzheimer's Disease (AD) Model from Plaques and Tangles
|
MORRISSETTE, DEBBIE
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$30,774
|
|
Alzheimer's Disease
|
NIA
|
1R01AG028746-01A2
|
|
Pioglitazone & Exercise Effects on Older Aldults with MCI and Metabolic Syndrome
|
SCHWARTZ, ROBERT
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$491,266
|
|
Alzheimer's Disease
|
NEI
|
5R01EY015855-02
|
|
Alzheimer disease biomarkers in lens
|
FREDERIKSE, PETER
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$266,315
|
|
Alzheimer's Disease
|
NINDS
|
5F31NS051957-03
|
|
The Role of Sortilin in Alzheimer's Disease
|
FINAN, GINA
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$36,578
|
|
Alzheimer's Disease
|
NIA
|
5R01AG026505-03
|
|
Age-Related Odor Memory Impairment in a Rodent Model
|
GILBERT, PAUL
|
SAN DIEGO STATE UNIVERSITY
|
CA
|
$193,637
|
|
Alzheimer's Disease
|
NIA
|
5R01AG023665-04
|
|
Microglial Dysfunction in Aged and Alzheimers's Brain
|
STREIT, WOLFGANG
|
UNIVERSITY OF FLORIDA
|
FL
|
$243,583
|
|
Alzheimer's Disease
|
NIDDK
|
1R21DK078710-01A1
|
|
ADAM 10-activated signaling in proximal tubule
|
BIEMESDERFER, DANIEL
|
YALE UNIVERSITY
|
CT
|
$248,063
|
|
Alzheimer's Disease
|
NIA
|
1R01AG028506-01A2
|
|
Mediterranean Diet and Other Dietary Patterns in Alzheimer's Disease
|
SCARMEAS, NIKOLAOS
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$506,219
|
|
Alzheimer's Disease
|
NIA
|
1K99AG031574-01A1
|
|
Synaptic dysregulation in a mouse model of Alzheimer's disease
|
NICHOLSON, DANIEL
|
NORTHWESTERN UNIVERSITY
|
IL
|
$90,001
|
|
Alzheimer's Disease
|
NIA
|
5R37AG017926-09
|
|
PS1 regulates processing and signaling of ephrinB/EphB
|
ROBAKIS, NIKOLAOS
|
MOUNT SINAI SCHOOL OF MEDICINE OF NYU
|
NY
|
$322,881
|
|
Alzheimer's Disease
|
NIA
|
5R01AG030149-02
|
|
Interleukin-1: A Mediator of Neuroinflammation and Alzheimer's Neuropathogenesis
|
O'BANION, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$309,386
|
|
Alzheimer's Disease
|
NIA
|
5R03AG030230-02
|
|
Imaging Cell Signaling Events During Luteinizing Hormone Pulses
|
ROESS, DEBORAH
|
COLORADO STATE UNIVERSITY-FORT COLLINS
|
CO
|
$64,827
|
|
Alzheimer's Disease
|
NIA
|
5R01AG026328-02
|
|
Gene-based TNF-alpha activity modulation in 3xTg-AD mice
|
BOWERS, WILLIAM
|
UNIVERSITY OF ROCHESTER
|
NY
|
$278,447
|
|
Alzheimer's Disease
|
NIA
|
5R21AG027320-02
|
|
Is S-adenosyl Methionine a Nutrition: Genetic Link in AD?
|
SHEA, THOMAS
|
UNIVERSITY OF MASSACHUSETTS LOWELL
|
MA
|
$160,353
|
|
Alzheimer's Disease
|
NIA
|
5R01AG026640-02
|
|
The role of the new zeta-cleavage in Abeta formation
|
XU, XUEMIN
|
UNIVERSITY OF TENNESSEE KNOXVILLE
|
TN
|
$291,305
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027544-02
|
|
Learning and Memory Impairments in a Transgenic AD Model with Plaques and Tangles
|
LAFERLA, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$301,096
|
|
Alzheimer's Disease
|
NIA
|
5R01AG020670-07
|
|
Developmental and Pathological Effects of Presenilin
|
ZHENG, HUI
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$301,350
|
|
Alzheimer's Disease
|
NIGMS
|
5K08GM073224-04
|
|
Volatile anesthetics, calcium homeostasis and apoptosis
|
WEI, HUAFENG
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$127,872
|
|
Alzheimer's Disease
|
NIA
|
1K23AG028727-01A2
|
|
Biological Underpinnings and Cognitive Expression of Brain Aging
|
LU, PO-HAONG
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$165,231
|
|
Alzheimer's Disease
|
NIDDK
|
5R21DK075494-02
|
|
Immunotherapy for Pancreatic Amylin Aggregates in Diabetes
|
SIGURDSSON, EINAR
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$248,430
|
|
Alzheimer's Disease
|
NIA
|
1U01AG028713-01A1
|
|
Calpain Inhibitors against Alzheimer's Disease
|
ARANCIO, OTTAVIO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$486,605
|
|
Alzheimer's Disease
|
NIA
|
2R01AG018454-07A2
|
|
Immune-Mediated Mechanisms Underlying CNS abeta Clearance
|
GOLDE, TODD
|
MAYO CLINIC COLL OF MED, JACKSONVILLE
|
FL
|
$313,650
|
|
Alzheimer's Disease
|
NICHD
|
5R01HD038466-08
|
|
Mitochondrial Dysfunction in Down's Syndrome
|
BUSCIGLIO, JORGE
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$188,650
|
|
Alzheimer's Disease
|
NIA
|
5T32AG000258-10
|
|
Neurobehavior, Neuroendocrinology, and Genetics of AD
|
CRAFT, SUZANNE
|
UNIVERSITY OF WASHINGTON
|
WA
|
$291,470
|
|
Alzheimer's Disease
|
NINR
|
5R01NR009675-02
|
|
Phase III Study of Donepezil in the Irradiated Brain
|
RAPP, STEPHEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$353,087
|
|
Alzheimer's Disease
|
NIA
|
1R21AG029840-01A1
|
|
Ultrahigh-resolution in vivo and ex vivo MRI of human medial temporal lobe
|
DICKERSON, BRADFORD
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$216,605
|
|
Alzheimer's Disease
|
NIMH
|
1R34MH078999-01A1
|
|
Telephone CBT For Depressed African-American Dementia Caregivers
|
GLUECKAUF, ROBERT
|
FLORIDA STATE UNIVERSITY
|
FL
|
$212,927
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS039080-08
|
|
INTEGRINS: LINKING SENILE PLAQUES AND NEURITIC DYSTROPHY
|
FERREIRA, ADRIANA
|
NORTHWESTERN UNIVERSITY
|
IL
|
$252,738
|
|
Alzheimer's Disease
|
NIMH
|
5K23MH068793-05
|
|
Cognitive Sequelae of early and mid-life depression
|
LEE, HOCHANG
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$154,565
|
|
Alzheimer's Disease
|
NIBIB
|
5R01EB006266-03
|
|
Shape Optimizing Diffeomorphisms for Computational Biology
|
GEE, JAMES
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$336,574
|
|
Alzheimer's Disease
|
NIMH
|
5R21MH080258-02
|
|
Protein Molecular Imaging in Patients with Late-Life Major Depression
|
KUMAR, ANAND
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$208,575
|
|
Alzheimer's Disease
|
NIA
|
5R01AG029547-02
|
|
Mechanism and Function of Sequential Proteolysis in Health and Disease
|
YU, GANG
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
TX
|
$283,872
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS051874-13
|
|
The Cdk5/p35 Kinase
|
TSAI, LI-HUEI
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
MA
|
$360,484
|
|
Alzheimer's Disease
|
NIA
|
5R01AG030197-02
|
|
Transcriptional Regulation of BACE and the Components of the gamma-Secretase Comp
|
XU, HUAXI
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
CA
|
$383,719
|
|
Alzheimer's Disease
|
NIA
|
5R21AG028462-02
|
|
A High Throughput Screen for Inhibitors of Aggregation of the Alzheimer's Peptide
|
HECHT, MICHAEL
|
PRINCETON UNIVERSITY
|
NJ
|
$164,518
|
|
Alzheimer's Disease
|
NIA
|
5R01AG023168-04
|
|
THE ROLE OF SULFATIDES IN ALZHEIMER'S DISEASE
|
HAN, XIANLIN
|
WASHINGTON UNIVERSITY
|
MO
|
$262,303
|
|
Alzheimer's Disease
|
NIA
|
5R01AG024180-03
|
|
MCI, Insulin and Cholesterol in a Community Sample
|
CRAFT, SUZANNE
|
SEATTLE INST FOR BIOMEDICAL/CLINICAL RES
|
WA
|
$511,015
|
|
Alzheimer's Disease
|
NCCAM
|
5R21AT003654-02
|
|
Stress Reduction for Caregivers: A Randomized Controlled Pilot Study
|
WHITEBIRD, ROBIN
|
HEALTHPARTNERS RESEARCH FOUNDATION
|
MN
|
$215,887
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS030454-18
|
|
Muscarinic Receptors in Alzheimer's Disease
|
LEVEY, ALLAN
|
EMORY UNIVERSITY
|
GA
|
$335,479
|
|
Alzheimer's Disease
|
NICHD
|
5R13NS048040-05
|
|
CSHL Molecular Chaperones and the Heat Shock Response
|
GRODZICKER, TERRI
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$3,000
|
|
Alzheimer's Disease
|
NINDS
|
5R13NS048040-05
|
|
CSHL Molecular Chaperones and the Heat Shock Response
|
GRODZICKER, TERRI
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$10,000
|
|
Alzheimer's Disease
|
NINDS
|
5R21NS052818-02
|
|
Phox2a/2b Function in the Mature Locus Coeruleus.
|
ZHU, MENG-YANG
|
EAST TENNESSEE STATE UNIVERSITY
|
TN
|
$191,625
|
|
Alzheimer's Disease
|
NINDS
|
5K08NS044978-05
|
|
PTEN Anti-Oncogene Influences on Neuronal Function & Toxicity
|
KAPLITT, MICHAEL
|
WEILL MEDICAL COLLEGE OF CORNELL UNIV
|
NY
|
$145,800
|
|
Alzheimer's Disease
|
NIA
|
5R01AG017753-08
|
|
Tyrosine Phosphorylation in Alzheimer's Disease
|
LEE, GLORIA
|
UNIVERSITY OF IOWA
|
IA
|
$255,803
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS046006-05
|
|
Vaccination and microglia in Alzheimer's mouse models
|
HEPPNER, FRANK
|
CHARITE, UNIVERSITAETSMEDIZIN BERLIN
|
GERM
|
$165,766
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS052305-03
|
|
Pathobiology of Vascular Cognitive Impairment
|
ROSENBERG, GARY
|
UNIVERSITY OF NEW MEXICO
|
NM
|
$310,475
|
|
Alzheimer's Disease
|
NIA
|
5R21AG027335-02
|
|
Vascular Comorbidities and DTI Measured White Matter Damage in AD
|
GOLDSTEIN, FELICIA
|
EMORY UNIVERSITY
|
GA
|
$159,311
|
|
Alzheimer's Disease
|
NINDS
|
5R37NS034467-10
|
|
Alzheimer's Abeta, apolipoproteins and blood-brain barrier
|
ZLOKOVIC, BERISLAV
|
UNIVERSITY OF ROCHESTER
|
NY
|
$452,031
|
|
Alzheimer's Disease
|
NICHD
|
5R01HD043960-05
|
|
The role of Mnbk in Downs Syndrome brain development and aging
|
WEGIEL, JERZY
|
INSTITUTE FOR BASIC RES IN DEV DISABIL
|
NY
|
$521,790
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS035144-11
|
|
Complement and Inflammatory Factors in AD Pathogenesis
|
TENNER, ANDREA
|
UNIVERSITY OF CALIFORNIA IRVINE
|
CA
|
$295,550
|
|
Alzheimer's Disease
|
NIGMS
|
5R01GM076201-02
|
|
Structure determination by vibrational spectroscopy
|
AXELSEN, PAUL
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$236,250
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS033981-12
|
|
Heparan sulfate proteoglycans in aging and development
|
COLE, GREGORY
|
NORTH CAROLINA CENTRAL UNIVERSITY
|
NC
|
$296,204
|
|
Alzheimer's Disease
|
NINDS
|
1R43NS061376-01
|
|
Targeted Aggregation Inhibitors for the Treatment of Amyloid Diseases
|
EKINS, SEAN
|
SNOWDON PHARMACEUTICALS, INC.
|
NJ
|
$132,948
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027429-03
|
|
O-GlcNAcylation of tau: a link between glucose metabolism and neurodegeneration
|
GONG, CHENG-XIN
|
INSTITUTE FOR BASIC RES IN DEV DISABIL
|
NY
|
$261,063
|
|
Alzheimer's Disease
|
NIA
|
5R37AG011762-14
|
|
Genomic Analysis of Alzheimer's Disease Genes
|
SCHELLENBERG, GERARD
|
UNIVERSITY OF WASHINGTON
|
WA
|
$248,797
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027852-02
|
|
Quantitative MRI of Iron Homeostasis, Atrophy and Tissue Structure in AD Brain
|
HELPERN, JOSEPH
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$472,597
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027161-02
|
|
Wisconsin Registry for Alzheimer Prevention: Biomarkers of Preclinical AD
|
SAGER, MARK
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$708,039
|
|
Alzheimer's Disease
|
NIGMS
|
5R01GM058445-09
|
|
Mechanism of regulation in the cyclin-dependent kinases
|
LEW, JOHN
|
UNIVERSITY OF CALIFORNIA SANTA BARBARA
|
CA
|
$252,643
|
|
Alzheimer's Disease
|
NIA
|
5R37AG006173-22
|
|
Aging in the Brain: The Role of the Fibrous Proteins
|
SELKOE, DENNIS
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$374,675
|
|
Alzheimer's Disease
|
FIC
|
5R21AG028187-02
|
|
Immunization Approaches for Alzheimer's Disease
|
WISNIEWSKI, THOMAS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$9,800
|
|
Alzheimer's Disease
|
NIA
|
5R21AG028187-02
|
|
Immunization Approaches for Alzheimer's Disease
|
WISNIEWSKI, THOMAS
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$107,085
|
|
Alzheimer's Disease
|
NIA
|
5R21AG027468-02
|
|
NO/cGMP/CREB pathway enhancers for treatment of Alzheimer's Disease
|
ARANCIO, OTTAVIO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$201,170
|
|
Alzheimer's Disease
|
NIA
|
2R44AG025641-03
|
|
Monoclonal Antibodies for Alzheimer's Immunotherapy
|
HIATT, ANDREW
|
MAPP BIOPHARMACEUTICAL, INC.
|
CA
|
$795,545
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS054880-03
|
|
New Roles for sAPP in Neuroprotection and Neurogenesis
|
LIAO, FRANCESCA-FANG
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
CA
|
$417,287
|
|
Alzheimer's Disease
|
NIA
|
2R42AG026950-02
|
|
SRF/MYOCD: new targets in Alzheimer's neurovasculature
|
MIANO, JOSEPH
|
SOCRATECH, LLC
|
NY
|
$498,129
|
|
Alzheimer's Disease
|
NIA
|
5F32AG020903-03
|
|
Mapping Novel Genes for Late-Onset Alzheimer's Disease
|
ERTEKIN-TANER, NILUFER
|
MAYO CLINIC COLL OF MED, JACKSONVILLE
|
FL
|
$58,036
|
|
Alzheimer's Disease
|
NINDS
|
1F31NS059193-01A1
|
|
Assessment of Alzheimer's Disease Risk with Structural and Functional MRI
|
BANGEN, KATHERINE
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$30,294
|
|
Alzheimer's Disease
|
NEI
|
1F32EY018787-01
|
|
Cholinergic mechanisms regulating neuronal responsiveness in the optic tectum
|
GODDARD, CARSON
|
STANFORD UNIVERSITY
|
CA
|
$46,826
|
|
Alzheimer's Disease
|
NINDS
|
5F31NS056731-02
|
|
Calcium Dysregulation and Inflammation in a Model of Alzheimer's Disease
|
PARK, KEIGAN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$40,972
|
|
Alzheimer's Disease
|
NIA
|
5R01AG027853-03
|
|
Mechanism of Amyloid Beta-Aggregation
|
ZAGORSKI, MICHAEL
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$271,251
|
|
Alzheimer's Disease
|
NIA
|
5R01AG018933-08
|
|
Beta Secretase Inhibition for Treating Alzheimer's Disease
|
TANG, JORDAN
|
OKLAHOMA MEDICAL RESEARCH FOUNDATION
|
OK
|
$466,591
|
|
Alzheimer's Disease
|
NIA
|
5R37AG025516-04
|
|
AMYLOID PATHOLOGY AND COGNITION IN NORMAL ELDERLY
|
KLUNK, WILLIAM
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$449,361
|
|
Alzheimer's Disease
|
NINDS
|
5R01NS048554-05
|
|
Vasopeptidases and Beta Amyloid Accumulation
|
ECKMAN, CHRISTOPHER
|
MAYO CLINIC COLL OF MED, JACKSONVILLE
|
FL
|
$270,138
|
|
Alzheimer's Disease
|
NINDS
|
1F31NS059283-01A1
|
|
Targeting Amyloid Beta Oligomers in the 3xTg-AD Mouse Model with scFv Antibodies
|
RYAN, DEBORAH
|
UNIVERSITY OF ROCHESTER
|
NY
|
$40,972
|
|
Alzheimer's Disease
|
NIA
|
5K23AG023040-05
|
|
Effects of Vascular Disease in Mild Cognitive Impairment
|
BOYLE, PATRICIA
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$115,560
|
|
Alzheimer's Disease
|
NIA
|
5R01AG022538-05
|
|
ISOLATED EXECUTIVE IMPAIRMENT AND COGNITIVE DECLINE
|
JOHNSON, JULENE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$241,298
|
|
Alzheimer's Disease
|
NIA
|
5R01AG025815-05
|
|
Understanding False Recognition in Alzheimer's Disease
|
BUDSON, ANDREW
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
MA
|
$240,017
|
|
Alzheimer's Disease
|
NIA
|
5R01AG024871-03
|
|
Neurobiologic Study of Psychological Distress & Dementia
|
WILSON, ROBERT
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$366,876
|
|
Alzheimer's Disease
|
NIA
|
5R01AG017870-07
|
|
Role of the Prolyl lsomerase Pin1 in Alzheimer's Disease
|
LU, KUN PING
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$307,377
|
|
Alzheimer's Disease
|
NINR
|
5R01NR009543-02
|
|
Clinical Trial to Enhance Caregiver Physical Activity
|
FARRAN, CAROL
|
RUSH UNIVERSITY MEDICAL CENTER
|
IL
|
$648,505
|
|
Alzheimer's Disease
|
NIGMS
|
5F32GM079931-02
|
|
Engineering An Enzyme for Rapid Profiling of Proteolytic Processing
|
WILDES, DAVID
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$46,826
|
|
Alzheimer's Disease
|
NIMH
|
5R01MH073982-04
|
|
Functional Neuroimaging of Strategic Retrieval Processes
|
DOBBINS, IAN
|
WASHINGTON UNIVERSITY
|
MO
|
$245,372
|
|
Alzheimer's Disease
|
NINDS
|
1F31NS060517-01A1
|
|
Effects of neural progenitor cell transplantation in neonatal Ts65Dn mice.
|
RACHUBINSKI, ANGELA
|
UNIVERSITY OF COLORADO DENVER
|
CO
|
$27,792
|
|
Alzheimer's Disease
|
NINDS
|
1F30NS059116-01A1
|
|
Assessment of cerebral metabolism in vivo by 17-Oxygen magnetic resonance imaging
|
MELLON, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$29,905
|
|
Alzheimer's Disease
|
NIA
|
5R01AG021925-05
|
|
Aging and Sites of Action of Cognition-Enhancing Drugs
|
WOODRUFF-PAK, DIANA
|
TEMPLE UNIVERSITY
|
PA
|
$273,082
|
|
